Veradermics (MANE) net assets (shareholders' equity)

Net assets · fiscal 2025
$143.46M

Veradermics (MANE) had net assets of $143.46M at the end of fiscal 2025 (December 31, 2025). That is 182.3% higher than the $50.82M of fiscal 2024. Figures as of 19 Nov 2026, 00:21 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
$143.46M
Change on fiscal 2024
+182.3%
Highest on record
$143.46Mfiscal 2025
Lowest on record
$13.72Mfiscal 2023
Fiscal years on record
32023–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Veradermics net assets (shareholders' equity), in more detail

Across the 3 fiscal years on record (2023–2025), the highest was $143.46M in fiscal 2025 and the lowest $13.72M in fiscal 2023.

History · 3 fiscal years

Net assets by fiscal year

Veradermics net assets (shareholders' equity), year by year

Veradermics (MANE) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$143.46M 182.3% up
2024$50.82M 270.3% up
2023$13.72M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Veradermics and comparable companies
CompanyNet assetsFiscal year
Scholar Rock Holding SRRK$245.49M2025
Teleflex TFX$3.12B2025
Mirum Pharmaceuticals MIRM$314.69M2025
Veradermics MANE$143.46M2025
Grifols GRFS€5.27B2025
Cogent Biosciences COGT$636.37M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MANE

Veradermics, figure by figure

Veradermics (MANE) overview: price, valuation and scorecardAll health care companies by market value

Veradermics net assets (shareholders' equity): questions and answers

What are Veradermics's net assets?

Veradermics (MANE) had net assets of $143.46M at the end of fiscal 2025 (December 31, 2025). That is 182.3% higher than the $50.82M of fiscal 2024.

What are the highest and lowest net assets figures on record for Veradermics?

Across the 3 fiscal years on record (2023–2025), the highest was $143.46M in fiscal 2025 and the lowest $13.72M in fiscal 2023.

How is Veradermics's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Veradermics it is on record here for 3 fiscal years, 2023 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Veradermics (MANE) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/MANE/net-assets

Underlying data: Yahoo Finance.